03 November 2023

Check Up #19 - Cancer immunotherapy

Cancer immunotherapy is any treatment that uses our own immune system to fight cancer. There are several types of immunotherapy, some of which are already being used routinely, and others still mostly experimental. They are generally a second line of treatment, following chemotherapy, radiotherapy or surgery. 

02 November 2023

Champalimaud Foundation launches screening for professionals exposed to asbestos

The new programme aims to increase the detection of MPM, focusing on workers at asbestos cement factories, in Portugal, who have been exposed to asbestos since the 1960’s, and covering a total of around 200 people who have already been identified by SOS Amianto.
 

INDP STUDENTS 2023

INDP 2023

Ana Martins (Canada/Portugal)
Arina Dygay (Russia)
Arjun Aji Reeja (India)
Beatriz Sebo (Portugal)
Devanshi Shah (India)
Guillermo Martín (Spain)
Kerem Sarikaya (Turkey)
Madalena Bettencourt (Portugal)
Miguel Donderis (Spain)
Prannay J. Reddy (India)
Robert Baber (Germany)

 

INDP 2023

 

27 October 2023

Free Breast Cancer Screening for Women under 50, living in Lisbon

This agreement, formally signed yesterday in a ceremony that took place at the Lisbon City Hall, will allow women under 50 in the city to undergo free breast cancer screenings. This initiative, set to be implemented by the end of the year, aims to tackle the alarming rise in cancer incidence among younger women.

18 October 2023

Champalimaud Foundation to Use Synthetic Biology in the Fight Against Cancer

The Champalimaud Foundation, a private non-profit research institution located in Lisbon, Portugal, has achieved a significant milestone in cancer research and pre-clinical development by obtaining exclusive rights to deploy synthetic biology technologies initially licensed from Stanford University and further developed by Refuge Biotechnologies (Refuge), a pioneering synthetic biology company specialising in cancer immunotherapy.

16 October 2023

Champalimaud Foundation scientists create health data cloud infrastructure for research for the first time in Portugal

A novel infrastructure for storing, consulting and analysing medical data will be presented at the Open Day of the Champalimaud Foundation (FC) Breast Unit, which is taking place today, October 16. It was created by the Unit's Digital Surgery Lab, a multidisciplinary team led by surgeon Pedro Gouveia, in partnership with the telecommunications company Altice and the Portuguese company BMD Software.

Artificial Intelligence: Paradigm Shift for Breast Cancer Patients

The Breast Unit of the Champalimaud Clinical Center organizes, for the 5th year, the Breast Unit Open Day, this year dedicated to Artificial Intelligence and its transformative impact on breast cancer patients.

28 September 2023

Check Up #18 - Side effects of cancer treatments. Can we classify them?

A side-effect “is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant”. 

Challenging Malignant Melanoma

Malignant melanoma is a highly aggressive form of skin cancer that is on the rise. However, recent breakthrough research has introduced new targeted therapies and immunotherapies for melanoma treatment, transforming the approach to treating melanoma and offering hope to patients with limited alternatives.

08 September 2023

Zoom-In on Champalimaud - 3rd Edition - Issue 7

World Physiotherapy Day has been celebrated since 1996, but 8 September was chosen as the date because this was when World Physiotherapy (a global collective of Physiotherapists) was founded in 1951.

The day marks the unity and solidarity of the global physiotherapy community. It is also an opportunity to recognise the work that physiotherapists do for their patients and community. 

Subscribe to Cancer
Loading
Please wait...